Clinical Trials Browser

Phase 2 × Transplantation, Autologous × Plasma cell × Clear all

NCT02244125 2025-11-24

PCD

Phase 2 Completed

Multiple Myeloma, Recurrence, Neoplasms, Plasma Cell

NCT01660633 2020-04-21

Safety & Efficacy Study High Dose Evomela Injection for MA Conditioning in MM Patients With Autologous Transplantation

Phase 2 Completed

Multiple Myeloma